Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 0.104M
June 30, 2026 -1.683M
March 31, 2026 185.83M
December 31, 2025 -0.111M
September 30, 2025 -0.152M
June 30, 2025 -0.168M
March 31, 2025 -0.214M
December 31, 2024 -0.194M
September 30, 2024 -0.204M
June 30, 2024 -0.18M
March 31, 2024 -0.209M
December 31, 2023 -0.431M
September 30, 2023 -2.534M
June 30, 2023 -7.946M
Date Value
March 31, 2023 -0.262M
December 31, 2022 -0.124M
September 30, 2022 -0.163M
June 30, 2022 -0.119M
March 31, 2022 0.119M
December 31, 2021 -0.118M
September 30, 2021 -0.007M
June 30, 2021 -0.011M
March 31, 2021 164.08M
December 31, 2020
September 30, 2020
June 30, 2020 0.556M
March 31, 2020 10.56M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 57.26M
Zymeworks, Inc. 330.62M
Rhythm Pharmaceuticals, Inc. -6.248M
Cue Biopharma, Inc. 50.63M
Yarrow Bioscience, Inc. 265.03M